MUMBAI, India (AP) -- India's largest pharmaceutical maker, Ranbaxy Laboratories Ltd., has retained former New York City mayor Rudy Guiliani to help it resolve a U.S. Food and Drug Administration ban on importing over 30 generic drugs, the company said Thursday.
On Tuesday, the FDA barred Ranbaxy from importing a raft of drugs -- including generic versions of the popular antibiotic Cipro and the cholesterol pill Zocor -- citing poor quality at two Ranbaxy factories in India.
Giuliani and Giuliani Partners, a consulting and investment firm, will provide advice and review compliance issues, the company said.
Last year, sales of generic drugs in the U.S. accounted for 23 percent of Ranbaxy's total revenue.
